ALLURION TECHNOLOGIES, INC. (ALUR)
Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Allurion Technologies Inc.
OTC:ALURHealthcare · Medical - Devices
$0.0100
Mkt Cap$600K
Float278K
O/S60.03M
Inst Own-
SI0.4%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$15.23M
Net Income-$28.75M
Total Assets$15.77M
Free Cash Flow-$28.95M
Debt & Equity
Total Debt$29.04M
Total Equity-$77.19M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
2-year cumulative
1:375Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:15Reverse splitJun 18, 202615 shares → 1
- 1:25Reverse splitJan 3, 202525 shares → 1
Balance Sheet Details
Assets$15.77M
Liabilities$92.96M
Accounts Receivable$3.95M
Accounts Payable$3.57M
Inventory$2.67M
PP&E (Net)$2.32M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $15.23M | $32.11M | $53.47M | $64.21M | $38.24M | $0 |
| YoY Growth | -52.6% | -39.9% | -16.7% | 67.9% | - | - |
| Cost of Revenue | $5.66M | $10.61M | $11.97M | $13.48M | $9.05M | $0 |
| Gross Profit | $9.57M | $21.5M | $41.5M | $50.73M | $29.19M | $0 |
| Gross Margin | 62.8% | 67.0% | 77.6% | 79.0% | 76.3% | - |
| Research and Development | $7.57M | $17.37M | $27.69M | $16.97M | $5.73M | $0 |
| Selling, General, and Administrative | $32.16M | $54.33M | $92.88M | $65.77M | $35.96M | $5K |
| Other | $0 | $0 | $0 | $0 | $0 | $610 |
| Total Operating Expenses | $39.73M | $71.7M | $120.58M | $82.74M | $41.69M | $5K |
| Operating Income (EBIT) | -$30.16M | -$50.2M | -$79.08M | -$32.01M | -$12.5M | -$5K |
| Operating Margin | -198.0% | -156.3% | -147.9% | -49.9% | -32.7% | - |
| Interest Expense | $0 | $2.26M | $10.57M | $4.43M | $3.67M | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $1.48M | $24.77M | -$1.26M | -$5.59M | $115K | $0 |
| Income Before Tax (EBT) | -$28.68M | -$25.43M | -$80.34M | -$37.6M | -$12.39M | -$5K |
| Income Tax Expense | $74K | $718K | $264K | $143K | $0 | $0 |
| Net Income | -$28.75M | -$26.15M | -$80.61M | -$37.74M | -$12.39M | -$5K |
| Net Income Margin | -188.8% | -81.4% | -150.8% | -58.8% | -32.4% | - |
| Supplementary Data | ||||||
| EPS | -57.15 | -48.00 | -890.70 | -566.25 | -47.39 | -0.02 |
| Diluted EPS | -57.15 | -48.00 | -890.70 | -566.25 | -47.39 | -0.02 |
| Weighted Average OS | 502,969 | 149,811 | 94,885 | 71,783 | 287,500 | 287,500 |
| EBITDA | -$27.7M | -$22.17M | -$69.03M | -$32.28M | -$8.01M | -$5K |
| EBITDA Margin | -181.9% | -69.0% | -129.1% | -50.3% | -20.9% | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $5.41M | $15.38M | $38.04M | $7.68M | $25.84M | $47K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $5.41M | $15.38M | $38.04M | $7.68M | $25.84M | $47K |
| Accounts Receivable | $3.95M | $7.13M | $18.19M | $29.35M | $6.83M | $0 |
| Inventory | $2.67M | $3.4M | $6.17M | $3.87M | $2.71M | $0 |
| Other Current Assets | $759K | $1.24M | $2.41M | $2.49M | $0 | $0 |
| Total Current Assets | $12.79M | $27.16M | $64.82M | $43.38M | $37.33M | $47K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $2.32M | $4.55M | $6.39M | $5.28M | $1.71M | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $384K | $0 | $862.55M | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $663K | $1.11M | $121K | $2.71M | -$862.24M | $283K |
| Total Long-Term Assets | $2.98M | $5.66M | $6.9M | $7.99M | $2.02M | $283K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $15.77M | $32.81M | $71.71M | $51.37M | $39.35M | $330K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $3.57M | $6.57M | $10.38M | $5.81M | $1.62M | $0 |
| Short-Term Debt | $28.47M | $0 | $38.64M | $53.36M | $24.14M | $170K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $202K | $0 |
| Other Current Liabilities | $6.41M | $1.05M | $13.81M | $3.45M | $2.23M | $140K |
| Total Current Liabilities | $38.45M | $18.86M | $65.42M | $75.87M | $31.61M | $310K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $571K | $35.71M | $36.2M | $3.1M | $2M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $53.95M | $54.87M | $74.47M | $2.55M | $40.02M | $0 |
| Total Long-Term Liabilities | $54.52M | $91.93M | $76.77M | $7.82M | $42.02M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $92.96M | $110.79M | $142.2M | $83.68M | $73.64M | $310K |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $57.97M | $0 |
| Common Stock | $6K | $3K | $5K | $3K | $51K | $2K |
| Retained Earnings | -$250.96M | -$222.21M | -$212.8M | -$132.19M | -$94.45M | -$5K |
| Comprehensive Income & Other | $5.14M | -$8.37M | -$700K | $0 | $0 | $0 |
| Other Stockholders' Equity | $173.77M | $144.23M | $142.31M | $99.88M | $60.11M | $23K |
| Total Equity | -$77.19M | -$77.98M | -$70.49M | -$32.31M | -$34.28M | $20K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $15.77M | $32.81M | $71.71M | $51.37M | $39.35M | $330K |
| Supplementary Data | ||||||
| Total Debt | $29.04M | $37.92M | $41.86M | $59.53M | $26.14M | $170K |
| Net Debt | $23.63M | $22.54M | $3.82M | $51.85M | $300K | $123K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | -$28.75M | -$26.15M | -$80.61M | -$37.74M | -$12.39M | -$5K |
| Depreciation & Amortization | $983K | $997K | $746K | $895K | $707K | $21 |
| Deferred Income Tax | $0 | $0 | $0 | $1.27M | $0 | $0 |
| Stock-Based Compensation | $3.15M | $3.06M | $8.36M | $437K | $313K | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $844K | $8.98M | -$1.32M | -$22.82M | -$927K | $0 |
| Inventory | -$486K | $543K | -$3.71M | -$1.15M | -$1.28M | $0 |
| Accounts Payable | -$3.14M | -$3.92M | $4.66M | $3.32M | -$488K | $0 |
| Other Working Capital | -$5.04M | -$4M | $553K | $6.86M | $1.21M | $5K |
| Total Working Capital Change | -$7.82M | $1.6M | $194K | -$13.79M | -$1.5M | $5K |
| Other Non-Cash Items | $3.5M | -$21.8M | $7.33M | $1.94M | -$1.47M | -$21 |
| Net Cash from Operating | -$28.95M | -$42.3M | -$63.98M | -$46.98M | -$14.33M | -$35 |
| Investing Activities | ||||||
| Capital Expenditures | $0 | -$611K | -$1.61M | -$1.55M | -$912K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | -$611K | -$1.61M | -$1.55M | -$912K | $0 |
| Financing Activities | ||||||
| Debt Repaid | -$795K | -$280K | -$71K | -$30.95M | -$19.07M | - |
| Common Stock Issuance | $18.97M | $21.26M | $213K | $132K | $523K | $25K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$795K | -$1.33M | $95.7M | -$548K | $1K | -$148K |
| Net Cash from Financing | $18.97M | $20.21M | $95.99M | $30.54M | $28.95M | $47K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$9.98M | -$22.7M | $30.4M | -$17.99M | $13.7M | $47K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$28.95M | -$42.3M | -$63.98M | -$46.98M | -$14.33M | -$35 |
| Capital Expenditure | $0 | -$611K | -$1.61M | -$1.55M | -$912K | -$5 |
| Free Cash Flow | -$28.95M | -$42.91M | -$65.59M | -$48.53M | -$15.24M | -$40 |
| Cash at Beginning | $15.72M | $38.42M | $8.02M | $26.02M | $12.31M | $0 |
| Cash at End | $5.74M | $15.72M | $38.42M | $8.02M | $26.02M | $47K |